Bristol-Myers Squibb was formed in 1989 with the merger of Bristol-Myers and Squibb Corporation.
Bristol-Myers was founded in 1887 by William McLaren Bristol and and John Ripley Meyers in Clinton, New York.
Squibb Corporation was founded by Edward Robinson Squibb in Brooklyn, New York in 1858.
Bristol-Myers Squibb is a pharmaceutical company that develops, licenses, manufacturers, markets, distributes, and sells biopharmaceutical products worldwide.
The company concentrates on cardiovascular care, immunology, metabolics, neuroscience, oncology, and virology.
Bristol-Myers Squibb is dedicated to the research and development of new drugs, and is in phase III clinical trials for various new treatments for HIV, different types of cancer, and Hepatitis C.
Bristol-Myers Squibb markets its products to health care practitioners, hospitals, and managed-care providers in 100 countries.
The company is a member trades publicly on the New York Stock Exchange under the symbol BMY, is #158 on the Fortune 500, is a member of the S&P 500, has 28,000 employees, and had $16.38 billion in revenue in 2013.
Bristol-Myers SquibbBristol-Myers Squibb was formed in 1989 with the merger of Bristol-Myers and Squibb Corporation.
Bristol-Myers was founded in 1887 by William McLaren Bristol and and John Ripley Meyers in Clinton, New York.
Squibb Corporation was founded by Edward Robinson Squibb in Brooklyn, New York in 1858.
History
Bristol-Myers Squibb is a pharmaceutical company that develops, licenses, manufacturers, markets, distributes, and sells biopharmaceutical products worldwide.
The company concentrates on cardiovascular care, immunology, metabolics, neuroscience, oncology, and virology.
Bristol-Myers Squibb is dedicated to the research and development of new drugs, and is in phase III clinical trials for various new treatments for HIV, different types of cancer, and Hepatitis C.
Bristol-Myers Squibb markets its products to health care practitioners, hospitals, and managed-care providers in 100 countries.
The company is a member trades publicly on the New York Stock Exchange under the symbol BMY, is #158 on the Fortune 500, is a member of the S&P 500, has 28,000 employees, and had $16.38 billion in revenue in 2013.